Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The Objective of this study is to investigate the long-term efficacy of intranasal oxytocin
in improvement of symptoms in patients with schizophrenia who have residual symptoms dispute
being on adequate treatment with antipsychotic medication.